AK Medical's (HKG:1789) attributable profit rose 50% to 273.9 million yuan in 2024 from 182.1 million yuan in 2023, according to a Wednesday filing with the Hong Kong bourse.
Earnings per share at the orthopedic products company increased to 0.24 yuan from 0.16 yuan in the previous year.
Revenue grew 23% to 1.35 billion yuan from 1.09 billion yuan a year earlier.
The company declared a final dividend of HK$0.072 per share, payable July 18 to shareholders on record as of June 18.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。